Project Grant R01AG087163
Award Date
12/15/24
Completion Date
11/30/29
Dollars Obligated
$780K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This Project Grant award, valued at $134,730.00, was issued by the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The goal of this project is to develop electroencephalogram (EEG) biomarkers to predict the future risk of dementia and monitor cognitive decline in older adults. The research will leverage existing datasets from the National Sleep Research...
This $295,000 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports Neurogeneces, Inc., a small business, in developing a machine learning algorithm to assess "brain age" from at-home EEG sleep data. The goal is to provide an objective, interpretable measure of age-adjusted brain function that can facilitate early detection of cognitive decline. Through this Phase I Small Business Technology Transfer (STTR) project, Neurogeneces will...
The National Institute on Aging (NIA) awarded Brigham & Women's Hospital Inc. a $2,576,936 Project Grant under the Aging Research federal grant program (CFDA 93.866) to characterize the variability in sleep spindle activity across a population and evaluate the use of sleep spindle dynamics as biomarkers for Alzheimer's disease, mild cognitive impairment, and trisomy 21. The 3-year project will develop statistical models and methods to analyze sleep spindle patterns and their relationship...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,498,158 to Synaptic Health LLC to develop a novel closed-loop feedback neuromodulation system for improving slow wave sleep in Alzheimer's disease patients. The goal is to create a prototype device that can sense sleep architecture and provide peripheral neuromodulation stimulation to individuals over 65, a high-risk group for Alzheimer's disease. The successful completion of this Phase I...
This Project Grant award from the National Institute on Aging (Federal Grant Program CFDA 93.866 - Aging Research) totaling $698,870.00 will support research to investigate the effects of thalamic stimulation on sleep oscillations in humans. The key products and services to be delivered under this award include: Studying the spatial extent of thalamic stimulation-evoked spindles and the disruption of spindles through real-time closed-loop stimulation in 50 patients with medication-refractory...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the bidirectional relationship between the spread of pathological protein aggregates, sleep, and circadian clock disruption in neurodegenerative diseases. The $2,181,132 award to Colorado State University, with a sub-award to the University of Massachusetts Amherst, will fund research to determine if neurodegenerative disease drives circadian and sleep disruption, if environmental...
This Project Grant award, with Federal Grant ID K23AG088497, was provided by the National Institute on Aging under the Aging Research federal grant program (CFDA 93.866). The $191,700 award supports the "SleepCog Study" led by Dr. Minjee Kim at Northwestern University, a research project investigating the relationship between sleep health, cognitive function, and risk of Alzheimer's disease and related dementias among middle-aged adults. The key objectives of this project are to: 1)...
This federal Project Grant award from the National Institute on Aging (Aging Research, CFDA 93.866) provides $4,027,679 to Boston University Medical Campus (Trustees of Boston University) to develop a digital cognitive health resource based on the Boston University Alzheimer's Disease Research Center (BU ADRC) cohort. The project aims to collect longitudinal digital cognitive metrics, assess their relationship with vascular risk factors and neuroanatomic measures, and build machine learning...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $258,498.00 to the University of California, Los Angeles (UCLA) to investigate the biological pathways linking sleep health to Alzheimer's disease and cognitive decline. The key objectives are to: Use a multi-omics approach to analyze methylation and metabolomics data associated with short sleep and insomnia among a high-risk Hispanic population, and compare the results to Alzheimer's...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $684,924 to Northwestern University to conduct research on the relationship between the noradrenergic (NA) system, sleep quality, and cognitive function in older adults with insomnia. The project aims to systematically characterize central and peripheral measures of the NA system and assess their association with sleep quality and cognitive performance in older adults with insomnia, as well as...